Literature DB >> 33386081

Network machine learning maps phytochemically rich "Hyperfoods" to fight COVID-19.

Ivan Laponogov1, Guadalupe Gonzalez2, Madelen Shepherd1, Ahad Qureshi1, Dennis Veselkov2,3, Georgia Charkoftaki4, Vasilis Vasiliou4, Jozef Youssef5, Reza Mirnezami6, Michael Bronstein2,7,8, Kirill Veselkov9,10.   

Abstract

In this paper, we introduce a network machine learning method to identify potential bioactive anti-COVID-19 molecules in foods based on their capacity to target the SARS-CoV-2-host gene-gene (protein-protein) interactome. Our analyses were performed using a supercomputing DreamLab App platform, harnessing the idle computational power of thousands of smartphones. Machine learning models were initially calibrated by demonstrating that the proposed method can predict anti-COVID-19 candidates among experimental and clinically approved drugs (5658 in total) targeting COVID-19 interactomics with the balanced classification accuracy of 80-85% in 5-fold cross-validated settings. This identified the most promising drug candidates that can be potentially "repurposed" against COVID-19 including common drugs used to combat cardiovascular and metabolic disorders, such as simvastatin, atorvastatin and metformin. A database of 7694 bioactive food-based molecules was run through the calibrated machine learning algorithm, which identified 52 biologically active molecules, from varied chemical classes, including flavonoids, terpenoids, coumarins and indoles predicted to target SARS-CoV-2-host interactome networks. This in turn was used to construct a "food map" with the theoretical anti-COVID-19 potential of each ingredient estimated based on the diversity and relative levels of candidate compounds with antiviral properties. We expect this in silico predicted food map to play an important role in future clinical studies of precision nutrition interventions against COVID-19 and other viral diseases.

Entities:  

Keywords:  Antiviral; COVID-19; Drug repositioning; Food; Gene-gene networks; Interactomics; Machine learning; SARS-CoV-2

Year:  2021        PMID: 33386081     DOI: 10.1186/s40246-020-00297-x

Source DB:  PubMed          Journal:  Hum Genomics        ISSN: 1473-9542            Impact factor:   4.639


  37 in total

1.  New uses for old drugs.

Authors:  Curtis R Chong; David J Sullivan
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

2.  Covid-19 and Disparities in Nutrition and Obesity.

Authors:  Matthew J Belanger; Michael A Hill; Angeliki M Angelidi; Maria Dalamaga; James R Sowers; Christos S Mantzoros
Journal:  N Engl J Med       Date:  2020-07-15       Impact factor: 91.245

3.  Rapid repurposing of drugs for COVID-19.

Authors:  R Kiplin Guy; Robert S DiPaola; Frank Romanelli; Rebecca E Dutch
Journal:  Science       Date:  2020-05-08       Impact factor: 47.728

Review 4.  Antiviral activity of phytochemicals: a comprehensive review.

Authors:  Rajesh Naithani; Loredana C Huma; Louis E Holland; Deepak Shukla; David L McCormick; Rajendra G Mehta; Robert M Moriarty
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

Review 5.  The food metabolome: a window over dietary exposure.

Authors:  Augustin Scalbert; Lorraine Brennan; Claudine Manach; Cristina Andres-Lacueva; Lars O Dragsted; John Draper; Stephen M Rappaport; Justin J J van der Hooft; David S Wishart
Journal:  Am J Clin Nutr       Date:  2014-04-23       Impact factor: 7.045

Review 6.  Flavonoids: an overview.

Authors:  A N Panche; A D Diwan; S R Chandra
Journal:  J Nutr Sci       Date:  2016-12-29

7.  HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods.

Authors:  Kirill Veselkov; Guadalupe Gonzalez; Shahad Aljifri; Dieter Galea; Reza Mirnezami; Jozef Youssef; Michael Bronstein; Ivan Laponogov
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

8.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

9.  Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Mária Földi; Nelli Farkas; Szabolcs Kiss; Noémi Zádori; Szilárd Váncsa; Lajos Szakó; Fanni Dembrovszky; Margit Solymár; Eszter Bartalis; Zsolt Szakács; Petra Hartmann; Gabriella Pár; Bálint Erőss; Zsolt Molnár; Péter Hegyi; Andrea Szentesi
Journal:  Obes Rev       Date:  2020-07-19       Impact factor: 10.867

Review 10.  Bioactive natural compounds against human coronaviruses: a review and perspective.

Authors:  Yanfang Xian; Juan Zhang; Zhaoxiang Bian; Hua Zhou; Zhenbiao Zhang; Zhixiu Lin; Hongxi Xu
Journal:  Acta Pharm Sin B       Date:  2020-06-08       Impact factor: 11.413

View more
  2 in total

Review 1.  Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.

Authors:  Laure-Alix Clerbaux; Maria Cristina Albertini; Núria Amigó; Anna Beronius; Gillina F G Bezemer; Sandra Coecke; Evangelos P Daskalopoulos; Giusy Del Giudice; Dario Greco; Lucia Grenga; Alberto Mantovani; Amalia Muñoz; Elma Omeragic; Nikolaos Parissis; Mauro Petrillo; Laura A Saarimäki; Helena Soares; Kristie Sullivan; Brigitte Landesmann
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

2.  The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic.

Authors:  Francesco Piccialli; Vincenzo Schiano di Cola; Fabio Giampaolo; Salvatore Cuomo
Journal:  Inf Syst Front       Date:  2021-04-26       Impact factor: 5.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.